Targeted Therapy

253 molecules in this therapeutic area. Open any product for its details, or send an inquiry directly.

Connect With Us

Targeted Therapy (147)

Quick filters: Solid Tumour Hematologic Both Name A-Z Name Z-A

Therapeutic Areas

Sort by

Clear all filters

Molecule	Drug Class / Mechanism	Oncology Type
Lerociclib	CDK Inhibitor	Solid Tumour
Molecule Lerociclib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism CDK Inhibitor
Lifirafenib	BRAF / MEK Inhibitor	Solid Tumour
Molecule Lifirafenib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Linifanib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Linifanib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Lirafugratinib	FGFR Inhibitor	Solid Tumour
Molecule Lirafugratinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism FGFR Inhibitor
Masitinib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Masitinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Masofaniten	Androgen Receptor Degrader (PROTAC)	Solid Tumour (Prostate)
Molecule Masofaniten Therapeutic Category Targeted Therapy Oncology Type Solid Tumour (Prostate) Drug Class / Mechanism Androgen Receptor Degrader (PROTAC)
Merestinib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Merestinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Mirdametinib	MEK1/2 Inhibitor	Solid Tumour
Molecule Mirdametinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism MEK1/2 Inhibitor
MK-2206 (AKT Inhibitor)	AKT Inhibitor	Solid Tumour
Molecule MK-2206 (AKT Inhibitor) Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism AKT Inhibitor
Motesanib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Motesanib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Naporafenib	BRAF / MEK Inhibitor	Solid Tumour
Molecule Naporafenib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Neratinib	EGFR / HER2 Tyrosine Kinase Inhibitor	Solid Tumour
Molecule Neratinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor

Lerociclib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism CDK Inhibitor
Lifirafenib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Linifanib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Lirafugratinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism FGFR Inhibitor
Masitinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Masofaniten Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour (Prostate) Drug Class / Mechanism Androgen Receptor Degrader (PROTAC)
Merestinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Mirdametinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism MEK1/2 Inhibitor
MK-2206 (AKT Inhibitor) Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism AKT Inhibitor
Motesanib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Naporafenib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Neratinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor

‹ 1 … 5 6 7 8 9 … 13 ›

Product Range

Company

Global Network

Targeted Therapy

Targeted Therapy (147)

Lerociclib

Lifirafenib

Linifanib

Lirafugratinib

Masitinib

Masofaniten

Merestinib

Mirdametinib

MK-2206 (AKT Inhibitor)

Motesanib

Naporafenib

Neratinib

Lerociclib

Lifirafenib

Linifanib

Lirafugratinib

Masitinib

Masofaniten

Merestinib

Mirdametinib

MK-2206 (AKT Inhibitor)

Motesanib

Naporafenib

Neratinib